Nu Skin Enterprises (NYSE:NUS) updated its third quarter 2019 earnings guidance on Tuesday. The company provided earnings per share guidance of $0.74-0.81 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.77. The company issued revenue guidance of $595-615 million, compared to the consensus revenue estimate of $615.55 million.Nu Skin Enterprises also updated its FY 2019 guidance to $3.20-3.35 EPS.
A number of brokerages have weighed in on NUS. ValuEngine upgraded shares of Nu Skin Enterprises from a strong sell rating to a sell rating in a research report on Thursday, August 1st. Citigroup cut their target price on shares of Nu Skin Enterprises from $86.00 to $52.00 and set a buy rating on the stock in a research report on Thursday, July 18th. Bank of America restated an underperform rating and issued a $52.00 target price (down previously from $57.00) on shares of Nu Skin Enterprises in a research report on Wednesday, June 19th. Jefferies Financial Group lowered shares of Nu Skin Enterprises from a buy rating to a hold rating and set a $40.00 target price on the stock. in a research report on Wednesday, July 17th. Finally, Zacks Investment Research upgraded shares of Nu Skin Enterprises from a sell rating to a hold rating in a research report on Friday, May 3rd. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The company has an average rating of Hold and an average price target of $55.63.
Nu Skin Enterprises stock traded up $0.36 during mid-day trading on Tuesday, reaching $38.54. The company had a trading volume of 493,300 shares, compared to its average volume of 697,075. The firm has a market cap of $2.17 billion, a P/E ratio of 10.95, a P/E/G ratio of 1.07 and a beta of 0.67. The company has a fifty day moving average of $44.20. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86. Nu Skin Enterprises has a fifty-two week low of $35.03 and a fifty-two week high of $85.92.
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Featured Article: Why do corrections happen?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.